https://www.drugtargetreview.com/article/108293/ovarian-cancer-breakthrough-the-potential-of-rhenium-tricarbonyl-trip-as-a-promising-anti-tumour-drug/
0
0
2/8/23 at 10:16am
Organization
Drug Target Review
38 words
0
Comments
In this exclusive article, Drug Target Review’s Izzy Wood highlights innovative ovarian cancer research from the Institute Krems Bioanalytics.
You are the first to view
Create an account
or login to join the discussion